Advertisement

International Journal of Colorectal Disease

, Volume 22, Issue 12, pp 1499–1507 | Cite as

C-reactive protein as early predictor for infectious postoperative complications in rectal surgery

  • T. Welsch
  • S. A. Müller
  • A. Ulrich
  • A. Kischlat
  • U. Hinz
  • P. Kienle
  • M. W. Büchler
  • J. Schmidt
  • B. M. Schmied
Original Article

Abstract

Background

This study evaluated the role of the acute phase C-reactive protein (CRP) in the postoperative course of a large series of rectal resections on the basis of a prospective database. Main focus of this study was the early identification of complications.

Materials and methods

Three hundred eighty-three rectal resections with primary anastomosis for rectal cancer were screened for infectious postoperative complications. Forty-eight complicated cases were identified and matched with 48 patients with an uneventful postoperative course.

Results

In the postoperative setting, CRP peaked on postoperative day (POD) 2 with a median serum CRP of 140 mg/l and gradually declined thereafter in uncomplicated cases. In complicated cases, CRP elevation generally persisted after POD 2, whereas white blood cells and body temperature were within normal range in the early postoperative period. A cutoff CRP value of 140 mg/dl on PODs 3 and 4 resulted in predictive values of 85.7 and 90.5% (adjusted to the prevalence: 37.6 and 50.3%), sensitivities of 80.0 and 54.3%, and specificities of 81.0 and 92.3% for a complicated postoperative course (P < 0.001), respectively.

Conclusion

Persistent CRP elevation and elevation of serum CRP above 140 mg/dl on PODs 3–4 are predictive of infectious postoperative complications and should prompt intense clinical search for an inflammatory process, especially for an anastomotic leak if pneumonia and wound infection are unlikely or excluded.

Keywords

C-reactive protein Rectal surgery Postoperative complications Anastomotic leak 

References

  1. 1.
    Tillet WS, Francis T (1930) Serological reactions in pneumonia with a non-protein somatic fraction of the pneumococcus. J Exp Med 52:561–571CrossRefGoogle Scholar
  2. 2.
    Gabay C, Kushner I (1999) Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 340:448–454CrossRefPubMedGoogle Scholar
  3. 3.
    Bang R, Marnell L, Mold C, Stein MP, Clos KT, Chivington-Buck C, Clos TW (2005) Analysis of binding sites in human C-reactive protein for FcγRI, FcγRIIA, and C1q by site-directed mutagenesis. J Biol Chem 280:25095–25102CrossRefPubMedGoogle Scholar
  4. 4.
    Venugopal SK, Devaraj S, Jialal I (2005) Effect of C-reactive protein on vascular cells: evidence for a proinflammatory, proatherogenic role. Curr Opin Nephrol Hypertens 14:33–37CrossRefPubMedGoogle Scholar
  5. 5.
    Pepys MB, Hirschfield GM (2003) C-reactive protein: a critical update. J Clin Invest 111:1805–1812CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Vermeire S, Van Assche G, Rutgeerts P (2006) Laboratory markers in IBD: useful, magic, or unnecessary toys? Gut 55:426–431CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Koenig W (2005) Predicting risk and treatment benefit in atherosclerosis: the role of C-reactive protein. Int J Cardiol 98:199–206CrossRefPubMedGoogle Scholar
  8. 8.
    Liuzzo G, Biasucci LM, Gallimore JR, Grillo RL, Rebuzzi AG, Pepys MB, Maseri A (1994) The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. N Engl J Med 331:417–424CrossRefPubMedGoogle Scholar
  9. 9.
    Yeh ET (2004) CRP as a mediator of disease. Circulation 109:II11–4CrossRefPubMedGoogle Scholar
  10. 10.
    Best LG, Zhang Y, Lee ET, Yeh JL, Cowan L, Palmieri V, Roman M, Devereux RB, Fabsitz RR, Tracy RP, Robbins D, Davidson M, Ahmed A, Howard BV (2005) C-reactive protein as a predictor of cardiovascular risk in a population with a high prevalence of diabetes: the Strong Heart Study. Circulation 112:1289–1295CrossRefPubMedGoogle Scholar
  11. 11.
    Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdottir G, Rumley A, Lowe GD, Pepys MB, Gudnason V (2004) C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 350:1387–1397CrossRefPubMedGoogle Scholar
  12. 12.
    Jamieson NB, Glen P, McMillan DC, McKay CJ, Foulis AK, Carter R, Imrie CW (2005) Systemic inflammatory response predicts outcome in patients undergoing resection for ductal adenocarcinoma head of pancreas. Br J Cancer 92:21–23CrossRefPubMedGoogle Scholar
  13. 13.
    Erlinger TP, Platz EA, Rifai N, Helzlsouer KJ (2004) C-reactive protein and the risk of incident colorectal cancer. JAMA 291:585–590CrossRefPubMedGoogle Scholar
  14. 14.
    Helzlsouer KJ, Erlinger TP, Platz EA (2006) C-reactive protein levels and subsequent cancer outcomes: Results from a prospective cohort study. Eur J Cancer 42:704–707CrossRefPubMedGoogle Scholar
  15. 15.
    Hashimoto K, Ikeda Y, Korenaga D, Tanoue K, Hamatake M, Kawasaki K, Yamaoka T, Iwatani Y, Akazawa K, Takenaka K (2005) The impact of preoperative serum C-reactive protein on the prognosis of patients with hepatocellular carcinoma. Cancer 103:1856–1864CrossRefPubMedGoogle Scholar
  16. 16.
    Buchler M, Malfertheiner P, Schoetensack C, Uhl W, Beger HG (1986) Sensitivity of antiproteases, complement factors and C-reactive protein in detecting pancreatic necrosis. Results of a prospective clinical study. Int J Pancreatol 1:227–235PubMedGoogle Scholar
  17. 17.
    Werner J, Hartwig W, Uhl W, Muller C, Buchler MW (2003) Useful markers for predicting severity and monitoring progression of acute pancreatitis. Pancreatology 3:115–127CrossRefPubMedGoogle Scholar
  18. 18.
    Reith HB, Mittelkotter U, Debus ES, Kussner C, Thiede A (1998) Procalcitonin in early detection of postoperative complications. Dig Surg 15:260–265CrossRefPubMedGoogle Scholar
  19. 19.
    Mustard RA Jr, Bohnen JM, Haseeb S, Kasina R (1987) C-reactive protein levels predict postoperative septic complications. Arch Surg 122:69–73CrossRefPubMedGoogle Scholar
  20. 20.
    Morley JJ, Kushner I (1982) Serum C-reactive protein levels in disease. Ann N Y Acad Sci 389:406–418CrossRefPubMedGoogle Scholar
  21. 21.
    Their M, Ronnholm K, Sairanen H, Holmberg C, Jalanko H (2002) Serum C-reactive protein in pediatric kidney and liver transplant patients. Pediatr Transplant 6:153–160CrossRefPubMedGoogle Scholar
  22. 22.
    Wullstein C, Drognitz O, Woeste G, Schareck WD, Bechstein WO, Hopt UT, Benz S (2004) High levels of C-reactive protein after simultaneous pancreas–kidney transplantation predict pancreas graft-related complications and graft survival. Transplantation 77:60–64CrossRefPubMedGoogle Scholar
  23. 23.
    Karanjia ND, Corder AP, Bearn P, Heald RJ (1994) Leakage from stapled low anastomosis after total mesorectal excision for carcinoma of the rectum. Br J Surg 81:1224–1226CrossRefPubMedGoogle Scholar
  24. 24.
    Law WL, Chu KW (2004) Anterior resection for rectal cancer with mesorectal excision: a prospective evaluation of 622 patients. Ann Surg 240:260–268CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Nesbakken A, Nygaard K, Lunde OC, Blucher J, Gjertsen O, Dullerud R (2005) Anastomotic leak following mesorectal excision for rectal cancer: true incidence and diagnostic challenges. Colorectal Dis 7:576–581CrossRefPubMedGoogle Scholar
  26. 26.
    Pakkastie TE, Luukkonen PE, Jarvinen HJ (1994) Anastomotic leakage after anterior resection of the rectum. Eur J Surg 160:293–297PubMedGoogle Scholar
  27. 27.
    Vignali A, Fazio VW, Lavery IC, Milsom JW, Church JM, Hull TL, Strong SA, Oakley JR (1997) Factors associated with the occurrence of leaks in stapled rectal anastomoses: a review of 1,014 patients. J Am Coll Surg 185:105–113CrossRefPubMedGoogle Scholar
  28. 28.
    Alberts JC, Parvaiz A, Moran BJ (2003) Predicting risk and diminishing the consequences of anastomotic dehiscence following rectal resection. Colorectal Dis 5:478–482CrossRefPubMedGoogle Scholar
  29. 29.
    Nesbakken A, Nygaard K, Lunde OC (2001) Outcome and late functional results after anastomotic leakage following mesorectal excision for rectal cancer. Br J Surg 88:400–404CrossRefPubMedGoogle Scholar
  30. 30.
    Yamamoto S, Fujita S, Akasu T, Moriya Y (2004) A comparison of the complication rates between laparoscopic colectomy and laparoscopic low anterior resection. Surg Endosc 18:1447–1451CrossRefPubMedGoogle Scholar
  31. 31.
    Millan M, Garcia-Granero E, Flor B, Garcia-Botello S, Lledo S (2006) Early prediction of anastomotic leak in colorectal cancer surgery by intramucosal pH. Dis Colon Rectum 49:595–601CrossRefPubMedGoogle Scholar
  32. 32.
    Yentis SM, Soni N, Sheldon J (1995) C-reactive protein as an indicator of resolution of sepsis in the intensive care unit. Intensive Care Med 21:602–605CrossRefPubMedGoogle Scholar
  33. 33.
    Claeys R, Vinken S, Spapen H, ver Elst K, Decochez K, Huyghens L, Gorus FK (2002) Plasma procalcitonin and C-reactive protein in acute septic shock: clinical and biological correlates. Crit Care Med 30:757–762CrossRefPubMedGoogle Scholar
  34. 34.
    Meisner M, Tschaikowsky K, Hutzler A, Schick C, Schuttler J (1998) Postoperative plasma concentrations of procalcitonin after different types of surgery. Intensive Care Med 24:680–684CrossRefPubMedGoogle Scholar
  35. 35.
    Sarbinowski R, Arvidsson S, Tylman M, Öresland T, Bengtsson A (2005) Plasma concentration of procalcitonin and systemic inflammatory response syndrome after colorectal surgery. Acta Anaesthesiol Scand 49:191–196CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2007

Authors and Affiliations

  • T. Welsch
    • 1
  • S. A. Müller
    • 1
  • A. Ulrich
    • 1
  • A. Kischlat
    • 1
  • U. Hinz
    • 2
  • P. Kienle
    • 1
  • M. W. Büchler
    • 1
  • J. Schmidt
    • 1
  • B. M. Schmied
    • 1
  1. 1.Department of General SurgeryUniversity of HeidelbergHeidelbergGermany
  2. 2.Unit for Documentation and StatisticsUniversity of HeidelbergHeidelbergGermany

Personalised recommendations